Skip to main content
Clinical Trials/CTRI/2024/05/067435
CTRI/2024/05/067435
Not yet recruiting
Phase 2

Integrated Pharmaceutical Care Programme in Patients with Diabetes Mellitus An Interventional Cross Sectional Prospective Study

Rishita Patel0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Sponsor
Rishita Patel
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Rishita Patel

Eligibility Criteria

Inclusion Criteria

  • Patients with Type\-II diabetes mellitus.
  • Patients with HbA1c more than 7%.
  • Patients who receiving oral hypoglycemic and/or insulin therapy.
  • Patients who provide written informed consent.
  • Patients who express willingness to participate in the study.

Exclusion Criteria

  • Patients who are younger than 18 years (They are legally regarded as dependents and consequently they cannot take decisions of their own).
  • Pregnant Women.
  • Patients who will not willing to give consent to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials